Search results
New Study Examines Genetic Risks Of Breast Cancer Among Black Women
Black Enterprise· 2 days agoData gathered as part of the NIH-funded African Ancestry Breast Cancer Genetic consortium will be...
Beyond Air shares hold Buy rating on positive data from a Phase 1a trial By Investing.com
Investing.com· 4 days agoOn Monday, BTIG reaffirmed its Buy rating and $10.00 stock price target for Beyond Air...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 2 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Zacks via Yahoo Finance· 7 days agoGilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or...
MD Anderson Research Highlights for June 5, 2024 | Newswise
Newswise· 2 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
MEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side...
Valley City Times Record· 5 days agoThe PRIMED study found a way to reduce treatment-related side effects among participants, decreasing...
Team presents promising results from first clinical trial of next-gen antibody in patients with...
Medical Xpress· 4 days agoThe ongoing trial has already included 104 patients with various types of tumors who had received between one and seven previous courses of treatment. Preliminary results from this phase 1 trial ...
Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting...
Morningstar· 6 days agoLUND, SWEDEN / ACCESSWIRE / June 1, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today gave a presentation at the ASCO conference showing clinical data on nadunolimab counteracting the serious problem of chemotherapy
On her own terms: Breanna Bortner tells her story of cancer bravely, beautifully - Austin Daily...
Austin Daily Herald· 2 days agoGenerally, people regard mosquitoes as an aggravation, irritation and annoyance, but for Breanna...
Gilead Sciences: Preserving Fertility in the Face of a Cancer Diagnosis
Morningstar· 2 days agoAccording to the National Breast Cancer Foundation, about 9% of women diagnosed with breast cancer in the United States are younger than 45 years old. While surgery and radiation rarely affect ...